Norbert Lubenow
Adjunct senior lecturer at Institutionen för immunologi, genetik och patologi; Forskningsprogram: Vaskulärbiologi; Forskargrupp Bo Nilsson
- E-mail:
- norbert.lubenow@igp.uu.se
- Visiting address:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postal address:
- Rudbecklaboratoriet
751 85 UPPSALA
More information is available to staff who log in.
Publications
Recent publications
- PET imaging of neutrophil elastase with 11C-GW457427 in Acute Respiratory Distress Syndrome in pigs (2023)
- International Forum on Home-Based Blood Transfusion (2022)
- Novel single nucleotide deletion in ART4 accounts for the Gy(a-) phenotype in a woman of Lebanese origin (2021)
- Patterns of blood use in Sweden from 2008 to 2017 (2020)
- Inadequate prophylactic effect of low-molecular weight heparin in critically ill COVID-19 patients (2020)
All publications
Articles
- PET imaging of neutrophil elastase with 11C-GW457427 in Acute Respiratory Distress Syndrome in pigs (2023)
- International Forum on Home-Based Blood Transfusion (2022)
- Novel single nucleotide deletion in ART4 accounts for the Gy(a-) phenotype in a woman of Lebanese origin (2021)
- Patterns of blood use in Sweden from 2008 to 2017 (2020)
- Inadequate prophylactic effect of low-molecular weight heparin in critically ill COVID-19 patients (2020)
- Perfusion of Porcine Kidneys With Macromolecular Heparin Reduces Early Ischemia Reperfusion Injury (2019)
- Patient was wrongly diagnosed and repeatedly treated for immune thrombocytopenia for 50 years (2018)
- High-Sensitivity Cardiac Troponin T (2018)
- The 99th percentile and imprecision of point-of-care cardiac troponin I in comparison to central laboratory tests in a large reference population (2017)
- An evaluation of the mixed pediatric unit for blood loss replacement in pediatric craniofacial surgery (2017)
- Standardizing the freeze-thaw preparation of growth factors from platelet lysate (2017)
- Motivational factors for blood donation in first-time donors and repeat donors (2017)
- Predonation finger lancet punctures (2016)
- Impact of physical activity of individuals and creatine kinase on 99th percentiles of troponin I assays (2016)
- Composition of growth factors and cytokines in lysates obtained from fresh versus stored pathogen-inactivated platelet units (2016)
- Analysis of Thromboelastography, PT, APTT and Fibrinogen in Intraosseous and Venous Samples (2016)
- Green plasma (2015)
- Perfusion Of Porcine Kidneys With Macromolecular Heparin Ameliorates Early Ischemia Reperfusion Injury (2015)
- Comparison of Three Fully Automated Systems for Immunohematology with the Focus on Two Important Aspects of Capacity-Efficiency and Stress (2014)
- Alternative diagnosis to heparin-induced thrombocytopenia in two critically ill patients despite a positive PF4/heparin-antibody test (2013)
- An Evaluation Of The Blood Donor Health Questionnaire (Dhq) In Sweden 2012 (2013)
- Resolution of Discrepancies Between Two Microcolumn Techniques for Antibody Screening in the Uppsala Region, Sweden (2012)
- Prophylactic platelet transfusions (2012)
- Heparin-induced thrombocytopenia (2010)
- The severity of trauma determines the immune response to PF4/heparin and the frequency of heparin-induced thrombocytopenia. (2010)
- [Thrombosis prophylaxis in trauma surgery units in Germany (2009)
- Heparin-induced thrombocytopenia (2007)
- Should patients be informed about the risk of heparin-induced thrombocytopenia before prolonged low-molecular-weight heparin thromboprophylaxis post-trauma/orthopedic surgery? (2007)
- IgG classification of anti-PF4/heparin antibodies to identify patients with heparin-induced thrombocytopenia during mechanical circulatory support. (2007)
- Profiling of alterations in platelet proteins during storage of platelet concentrates. (2007)
- Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia. (2006)
- Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical practice during the 1990s. (2006)
- Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3. (2005)
- Antibodies against lepirudin are polyspecific and recognize epitopes on bivalirudin. (2004)
- Heparin-induced thrombocytopenia in children (2004)
- Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparin-induced thrombocytopenia (2004)
- CpG-A and CpG-B oligonucleotides differentially enhance human peptide-specific primary and memory CD8+ T-cell responses in vitro. (2004)
- Ex vivo analysis of human antigen-specific CD8+ T-cell responses (2004)
- Effector function of human tumor-specific CD8 T cells in melanoma lesions (2004)
- Platelet receptor and clotting factor polymorphisms as genetic risk factors for thromboembolic complications in heparin-induced thrombocytopenia. (2003)
- Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia. (2003)
- Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells. (2003)
- [Informed consent on heparin-induced thrombocytopenia during thrombosis prophylaxis. A pilot study including 460 patients]. (2003)
- New developments in diagnosis and treatment of heparin-induced thrombocytopenia. (2003)
- Heparin-induced thrombocytopenia and cardiopulmonary bypass (2003)
- The new ID-heparin/PF4 antibody test for rapid detection of heparin-induced antibodies in comparison with functional and antigenic assays. (2002)
- [Current recommendations for diagnosis and therapy of heparin-induced thrombocytopenia]. (2002)
- [Hirudins in the treatment of heparin-induced thrombocytopenia and in thrombosis prophylaxis]. (2002)
- Hirudin in heparin-induced thrombocytopenia. (2002)
- Heparin-induced thrombocytopenia (2002)
- Drug-induced and drug-dependent immune thrombocytopenias. (2001)
- Recombinant hirudin in clinical practice (2001)
- Drugs for the prevention and treatment of thrombosis in patients with heparin-induced thrombocytopenia. (2001)
- Emergency cardiopulmonary bypass in a bilaterally nephrectomized patient with a history of heparin-induced thrombocytopenia (2001)
- Glucosamine sulfate does not crossreact with the antibodies of patients with heparin-induced thrombocytopenia. (2001)
- Antihirudin antibodies in patients with heparin-induced thrombocytopenia treated with lepirudin (2000)
- Heparin-induced thrombocytopenia with thromboembolic complications (2000)
- Very low platelet counts in post-transfusion purpura falsely diagnosed as heparin-induced thrombocytopenia. Report of four cases and review of literature. (2000)
- Management of patients with heparin-induced thrombocytopenia (2000)
- Heparin-induced thrombocytopenia (2000)
- Heparin-platelet factor (PF) 4 antibodies in patients with pseudothrombocytopenia (2000)
- Phenylketonuria screening with a fluorometric microplate assay. (1994)
